-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$171M, a 55.5% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$599M, a 192% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$599M, a 192% decline from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$205M, a 16.6% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$176M, a 25% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)